个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Xiangfeng Lu[1] ; Zhongying Liu[1] ; Qingmei Cui[1] ; Fangchao Liu[1] ; Jianxin Li [1] ; Xiaoge Niu[1] ; Chong Shen[2] ; Dongsheng Hu[3,4] ; Keyong Huang[1] ; Jichun Chen[1] ; Xiaolong Xing[1] ; Yingxin Zhao[5] ; Fanghong Lu[5] ; Xiaoqing Liu[6] ; Jie Cao[1] ; Shufeng Chen[1] ; Hongxia Ma [2] ; Ling Yu[7] ; Xianping Wu[8] ; Xigui Wu[1] ; Ying Li [1] ; Huan Zhang[9] ; Xingbo Mo[9] ; Liancheng Zhao[1] ; Jianfeng Huang[1] ; Laiyuan Wang[1] ; Wanqing Wen [10] ; Xiao-Ou Shu [10] ; Fumihiko Takeuchi [11] ; Woon-Puay Koh [12] ; E Shyong Tai[13,14] ; Ching-Yu Cheng [15] ; Tien yin Wong [15,16] ; Xuling Chang [17,18] ; Mark Yan-Yee Chan [19,20] ; Wei Gao [21] ; Hong Zheng[22] ; Kexin Chen[22] ; Jing Chen[23] ; Jiang He [24] ; Clara Sze-man Tang [25] ; Karen Siu Ling Lam [26] ; Hung-fat Tse [26] ; Chloe Yu Yan Cheung[26] ; Atsushi Takahashi [27,28] ; Michiaki Kubo [27] ; Norihiro Kato [11] ; Chikashi Terao [27] ; Yoichiro Kamatani [27,29] ; Pak Chung Sham[30] ; Chew-Kiat Heng [17] ; Zhibin Hu[2] ; Y. Eugene Chen [31] ; Tangchun Wu[32] ; Hongbing Shen [2] ; Cristen J Willer[31,33] ; Dongfeng Gu [1] ;
机构： [1]Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center forCardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China [2]Department of Epidemiology and Biostatistics, School ofPublic Health, Nanjing Medical University, Nanjing 211166, China [3]Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou450001, China [4]Department of Biostatistics and Epidemiology, School of Public Health, Shenzhen University Health Science Center, Shenzhen 518071, China [5]CardioCerebrovascular Control and Research Center, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan 250062, China [6]Division of Epidemiology, GuangdongProvincial People’s Hospital and Cardiovascular Institute, Guangzhou 510080, China [7]Department of Cardiology, Fujian Provincial People’s Hospital, Fuzhou 350014, China [8]Sichuan Center for Disease Control and Prevention, Chengdu 610041, China [9]Center for Genetic Epidemiology and Genomics, School of Public Health and Jiangsu Key Laboratoryof Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, China [10]Department of Medicine, Vanderbilt UniversityMedical Center, Nashville, TN, USA [11]Department of Gene Diagnostics and Therapeutics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan [12]Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore [13]Saw Swee Hock School ofPublic Health, National University of Singapore and National University Health System, Singapore [14]Department of Medicine, Yong Loo Lin School of Medicine, National UniversityHealth System, Singapore [15]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore [16]Ophthalmology and Visual Sciences Academic Clinical Program, DukeNUS, Medical School, Singapore [17]Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore [18]Khoo Teck Puat—NationalUniversity Children’s Medical Institute, National University Health System, Singapore [19]Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore,Singapore [20]National University Heart Centre, National University Health System, Singapore [21]Department of Cardiology, Institute of Vascular Medicine, Peking University ThirdHospital, Beijing, China [22]Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin Key Laboratory of Breast Cancer Prevention andTherapy, Ministry of Education, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China [23]Department of Medicine,Tulane University School of Medicine, and Tulane University Translational Science Institute, New Orleans, LA, USA [24]Department of Epidemiology, Tulane University School ofPublic Health and Tropical Medicine, and Tulane University Translational Science Institute, New Orleans, LA, USA [25]Department of Surgery, Li Ka Shing Faculty of Medicine, TheUniversity of Hong Kong, Hong Kong, China [26]Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China [27]Laboratory for Statisticaland Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan [28]Department of Genomic Medicine, Research Institute, National Cerebral andCardiovascular Center, Osaka, Japan [29]Laboratory of Complex Trait Genomics, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan [30]Centre forPanorOmic Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China [31]Department of Internal Medicine, Division of Cardiovascular Medicine,University of Michigan, Ann Arbor, MI, USA [32]MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science &Technology, Wuhan 430030, China [33]Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA
出处：
DOI： 10.1093/eurheartj/ehac093
ISSN：

关键词： Coronary artery disease • Polygenic risk score • Clinical risk score

摘要：
To construct a polygenic risk score (PRS) for coronary artery disease (CAD) and comprehensively evaluate its potential in clinical utility for primary prevention in Chinese populations.Using meta-analytic approach and large genome-wide association results for CAD and CAD-related traits in East Asians, a PRS comprising 540 genetic variants was developed in a training set of 2800 patients with CAD and 2055 controls, and was further assessed for risk stratification for CAD integrating with the guideline-recommended clinical risk score in large prospective cohorts comprising 41 271 individuals. During a mean follow-up of 13.0 years, 1303 incident CAD cases were identified. Individuals with high PRS (the highest 20%) had about three-fold higher risk of CAD than the lowest 20% (hazard ratio 2.91, 95% confidence interval 2.43-3.49), with the lifetime risk of 15.9 and 5.8%, respectively. The addition of PRS to the clinical risk score yielded a modest yet significant improvement in C-statistic (1%) and net reclassification improvement (3.5%). We observed significant gradients in both 10-year and lifetime risk of CAD according to the PRS within each clinical risk strata. Particularly, when integrating high PRS, intermediate clinical risk individuals with uncertain clinical decision for intervention would reach the risk levels (10-year of 4.6 vs. 4.8%, lifetime of 17.9 vs. 16.6%) of high clinical risk individuals with intermediate (20-80%) PRS.The PRS could stratify individuals into different trajectories of CAD risk, and further refine risk stratification for CAD within each clinical risk strata, demonstrating a great potential to identify high-risk individuals for targeted intervention in clinical utility.The incorporation of polygenic risk into clinical care setting may provide a valuable risk stratification guidance to identify high-risk individuals for targeted intervention in primary prevention of CAD.© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology.

基金：
This work was supported by Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2021-I2M-1-010, 2019-I2M-2-003, 2017-I2M-1-004), National Natural Science Foundation of China (82030102, 12126602, 91857118), and National Key Research and Development Program of China (2018YFE0115300, 2017YFC0211700).
语种：
外文
高被引：
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
JCR分区：
出版当年[2022]版：
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版：
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center forCardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
通讯作者：
推荐引用方式(GB/T 7714)：
Xiangfeng Lu,Zhongying Liu,Qingmei Cui,et al.A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.[J].EUROPEAN HEART JOURNAL.2022,43(18):1702-+.doi:10.1093/eurheartj/ehac093.
APA：
Xiangfeng Lu,Zhongying Liu,Qingmei Cui,Fangchao Liu,Jianxin Li...&Dongfeng Gu.(2022).A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study..EUROPEAN HEART JOURNAL,43,(18)
MLA：
Xiangfeng Lu,et al."A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.".EUROPEAN HEART JOURNAL 43..18(2022):1702-+

相关文献

[1]医院后勤精细化管理策略研究 [2]个性化目标教学在神经外科护理实习生带教中的应用 [3]纳米增强免疫比浊法和高效液相色谱法检测化疗患者5-氟尿嘧啶血药浓度的比较 [4]徒手淋巴引流对乳腺癌术后淋巴水肿的治疗效果分析 [5]护理干预在减轻妇科恶性肿瘤腹部术后疼痛中的效果 [6]心理护理对肿瘤介入治疗患者生活质量的影响 [7]某院2400张门诊中成药处方分析 [8]人文关怀在恶性肿瘤护理中的应用效果分析 [9]综合护理干预对肺癌化疗患者生活质量的影响 [10]外涂万花油对化疗性静脉炎的预防及疗效

资源点击量：43377 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号